Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation

Sponsor
University Health Network, Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT01404780
Collaborator
(none)
70
1
2
20.1
3.5

Study Details

Study Description

Brief Summary

Patients undergoing chest surgery often require insertion of a breathing tube (double lumen tube) after they are unconscious. The double lumen tube enables the anaesthetist to ventilate (assist breathing) one lung at a time. The other lung is partially deflated to enable enough space for the surgeon to perform the procedure. The breathing tube is inserted with a laryngoscope (blade with a light at the end) so the vocal cords can be seen. This is standard medical practise. Two laryngoscopes are commonly used at Toronto General Hospital to insert the tube. The Macintosh laryngoscope has been is use for over 50 years and the Glidescope for over 10 years. Both devices have been extensively researched for single lumen tubes insertion and found to be very safe and effective. Research is limited to say which of the two laryngoscope is the most effective for double lumen tubes.

Condition or Disease Intervention/Treatment Phase
  • Device: GlideScope (GVL)
  • Device: Macintosh Direct Laryngoscope (MDL)
N/A

Detailed Description

The Glidescope (GVL) has been extensively studied for single lumen tube intubation and found to be a very safe and useful device. It is a particularly useful for patients with difficult airways as it has a camera attached to the blade. Despite being used for double lumen tube (DLT) intubations, research of its effectiveness and safety, is lacking. The study aims to determine the speed and safety of the GVL for DLT insertion. This information will assist anaesthetists in choosing the appropriate laryngoscope for DLT intubation of their patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Aug 1, 2012
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: The GlideScope (GVL)

Device: GlideScope (GVL)
The Glidescope (GVL) has not been extensively studied for double lumen tube intubation. The GVL may be particularly useful for patients with difficult airways as it has a camera attached to the blade.

Active Comparator: Macintosh direct laryngoscope (MDL)

Device: Macintosh Direct Laryngoscope (MDL)
Current standard of care at UHN for 50 years

Outcome Measures

Primary Outcome Measures

  1. Time to intubation (laryngoscope or DLT inserted between patient's lips to DLT placement in the trachea and laryngoscope withdrawal) [Number of minutes (0-2) that is required to intubate will be recorded, if a 2nd attempt is required, duration to successfull intubation will be recorded in minutes.]

    Patients will be randomized to either MDL or GVL. If the first attempt fails to intubate within 2 minutes the anesthetist will remove the laryngoscope and provide mask ventilation. The second intubation attempt the anesthetist is encouraged to use the same randomized laryngoscope however, if the treating anesthetist feels a different device and technique will have a higher success rate they can perform that technique on the second attempt regardless of the randomized device. Anesthetists will complete a questionnaire after intubation.

Secondary Outcome Measures

  1. Time to lung isolation, difficulty of the procedure, complication to the patients [From the beginning of the operative procedure through to 24 hours postoperatively]

    Information about the procedure (times and complications) will be collected and documented by the study Anesthetist and questionnaires completed at the end of the 24hr postoperative period. Visits: patients will be followed up for a 24 hour period either on ward or by telephone if discharged, and assessed for sore throat, hoarseness, trauma to mouth and lips, dental damage and swallowing difficulties.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Population: planned elective lung surgery requiring general anaesthesia with a double lumen endotracheal intubation, signed informed patient consent.

Exclusion Criteria:
  • Previous failed intubation,

  • history of difficult intubation or anticipated difficult intubation (2 risk factors of mallampati score 3 or greater,

  • incisor gap < 3.5cm, thyromental distance < 6.5cm,

  • reduced neck extension and flexion),

  • alternative method of intubation indicated eg rapid sequence intubation,

  • fibreoptic intubation,

  • contra-indication to a left double lumen tube eg endobronchial tumor,

  • significant deviation or compression of the trachea and bronchi.,

  • contraindication to one lung ventilation eg severe hypoxia or pulmonary hypertension,

  • anticipated difficult bag mask ventilation,

  • symptomatic gastro-oesophageal reflux,

  • oral/pharyngeal/laryngeal carcinoma,

  • loose teeth,

  • allergy to rocuronium, BMI > 40.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Toronto General Hospital Toronto Ontario Canada M5G 2C4

Sponsors and Collaborators

  • University Health Network, Toronto

Investigators

  • Principal Investigator: Adriaan Van Rensburg, MD, University Health Network, Toronto General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01404780
Other Study ID Numbers:
  • 11-0270-B
First Posted:
Jul 28, 2011
Last Update Posted:
Feb 22, 2013
Last Verified:
Feb 1, 2013
Keywords provided by University Health Network, Toronto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 22, 2013